Popularized in films like Limitless, legal smart drugs called Nootropics are becoming more and more prevalent in board rooms and on Wall Street.Keep reading »
Sidney Gilman—Alzheimer’s specialist, former University of Michigan medical professor and confessed provider of confidential information to the hedge-fund set—used his final moments on the witness stand to offer one more contribution to science.
Dr. Gilman testified this week that he met with Mr. Martoma on July 19, 2008, at his office at the University of Michigan in Ann Arbor and discussed the results. But under cross-examination, Dr. Gilman conceded he initially told prosecutors during meetings in 2011 and 2012 he had no memory of the meeting, despite a calendar entry recording it.
Richard Strassberg, an attorney for Mr. Martoma, asked Dr. Gilman if he only realized the meeting was important to prosecutors after they raised it repeatedly during meetings with him. Dr. Gilman was motivated by a desire to stay out of jail, Mr. Strassberg suggested.
By early 2013, Dr. Gilman recalled the meeting, he said, and details of it came back to him as recently as October.
“It was an evolutionary process,” he said Friday.